391 related articles for article (PubMed ID: 12944058)
21. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.
Sun Z; Fu Q; Cao L; Jin W; Cheng L; Li Z
PLoS One; 2013; 8(1):e55124. PubMed ID: 23383076
[TBL] [Abstract][Full Text] [Related]
22. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
23. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
24. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
[TBL] [Abstract][Full Text] [Related]
25. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
26. A drug to prevent renal failure?
Kellum JA
Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054
[No Abstract] [Full Text] [Related]
27. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.
Kang X; Hu DY; Li CB; Ai ZS; Peng A
Ren Fail; 2015 Nov; 37(10):297-303. PubMed ID: 26458505
[TBL] [Abstract][Full Text] [Related]
28. Acetylcysteine and contrast media nephropathy.
Tepel M; Zidek W
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):503-6. PubMed ID: 12187314
[TBL] [Abstract][Full Text] [Related]
29. Acetylcysteine for radiocontrast nephropathy.
Tepel M; Zidek W
Curr Opin Crit Care; 2001 Dec; 7(6):390-2. PubMed ID: 11805540
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
Albabtain MA; Almasood A; Alshurafah H; Alamri H; Tamim H
J Interv Cardiol; 2013 Feb; 26(1):90-6. PubMed ID: 22994682
[TBL] [Abstract][Full Text] [Related]
31. Prevention of contrast-induced nephropathy in vascular surgery patients.
Lawlor DK; Moist L; DeRose G; Harris KA; Lovell MB; Kribs SW; Elliot J; Forbes TL
Ann Vasc Surg; 2007 Sep; 21(5):593-7. PubMed ID: 17823041
[TBL] [Abstract][Full Text] [Related]
32. Prevention of contrast nephropathy in critically ill patients using acetylcysteine and theophylline.
Mueller C
Int J Artif Organs; 2004 Dec; 27(12):1066-9. PubMed ID: 15645617
[TBL] [Abstract][Full Text] [Related]
33. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
[TBL] [Abstract][Full Text] [Related]
34. Current trials of interventions to prevent radiocontrast-induced nephropathy.
Asif A; Garces G; Preston RA; Roth D
Am J Ther; 2005; 12(2):127-32. PubMed ID: 15767830
[TBL] [Abstract][Full Text] [Related]
35. Radiocontrast-induced acute renal failure.
Weisbord SD; Palevsky PM
J Intensive Care Med; 2005; 20(2):63-75. PubMed ID: 15855219
[TBL] [Abstract][Full Text] [Related]
36. Prevention of radiocontrast-induced nephropathy.
Asif A; Epstein M
Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433
[TBL] [Abstract][Full Text] [Related]
37. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
Coyle LC; Rodriguez A; Jeschke RE; Simon-Lee A; Abbott KC; Taylor AJ
Am Heart J; 2006 May; 151(5):1032.e9-12. PubMed ID: 16644332
[TBL] [Abstract][Full Text] [Related]
38. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
Durham JD; Caputo C; Dokko J; Zaharakis T; Pahlavan M; Keltz J; Dutka P; Marzo K; Maesaka JK; Fishbane S
Kidney Int; 2002 Dec; 62(6):2202-7. PubMed ID: 12427146
[TBL] [Abstract][Full Text] [Related]
39. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Navaneethan SD; Singh S; Appasamy S; Wing RE; Sehgal AR
Am J Kidney Dis; 2009 Apr; 53(4):617-27. PubMed ID: 19027212
[TBL] [Abstract][Full Text] [Related]
40. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Ng TM; Shurmur SW; Silver M; Nissen LR; O'Leary EL; Rigmaiden RS; Cieciorka M; Porter LL; Ineck BA; Kline ME; Puumala SE
Int J Cardiol; 2006 May; 109(3):322-8. PubMed ID: 16039733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]